TABLE 10.
Monocytes | RT | RC | SET | SEC | p between groups* | p between groups # | |||
---|---|---|---|---|---|---|---|---|---|
RT | RC | SET | SEC | ||||||
Classical | 95.25 (9.80) | 90.86 (5.47) | 97.89 (6.48) | 81.82 (6.43) | .126 | ||||
Intermediate | 268.87 (23.04) | 313.81 (29.95) | 360.67 (37.75) | 264.54 (21.93) | .086 | <.0001 | <.0001 | <.0001 | <.0001 |
Non-classical | 63.13 (6.31) | 119.54 (40.41) | 193.20 (81.16) | 64.09 (5.90) | .334 |
Data represent means (standard errors of means–SEM). Kruskal-Wallis test, *comparisons between treatment arms and # comparisons between groups of monocytes (classical × intermediate × non-classical). RT, Rosuvastatin + Ticagrelor; RC, Rosuvastatin + Clopidogrel; SET, Simvastatin + Ezetimibe + Ticagrelor; SEC, Simvastatin + Ezetimibe + Clopidogrel; a.u, fluorescence arbitrary units.